$AMRI Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ALBANY MOLECULAR RESEARCH INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in ALBANY MOLECULAR RESEARCH INC. Get notifications about new insider transactions in ALBANY MOLECULAR RESEARCH INC for free.

Page: < prev 1 ... 2 3 4 5 6 7 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Aug 13 2012	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	3.00	3,000	9,000	29,242	32.2 K to 29.2 K (-9.30 %)
Jun 14 2012	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Option Exercise	A	2.59	10,000	25,900	10,000
Jun 14 2012	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Option Exercise	A	2.59	10,000	25,900	10,000
Jun 14 2012	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Option Exercise	A	2.59	10,000	25,900	10,000
Jun 14 2012	AMRI	ALBANY MOLECULAR R ...	Marth William S	Director	Option Exercise	A	2.59	10,000	25,900	10,000
Jun 14 2012	AMRI	ALBANY MOLECULAR R ...	LEUNG GABRIEL	Director	Option Exercise	A	2.59	10,000	25,900	10,000
Jun 12 2012	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	D	0.00	1,250	0	50,762	52 K to 50.8 K (-2.40 %)
Jun 14 2012	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Option Exercise	A	2.59	10,000	25,900	10,000
Jun 12 2012	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, general counsel	Sell	D	0.00	1,458	0	37,774	39.2 K to 37.8 K (-3.72 %)
Jun 12 2012	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	D	0.00	1,250	0	32,242	33.5 K to 32.2 K (-3.73 %)
Jun 12 2012	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Sell	D	0.00	1,667	0	74,599	76.3 K to 74.6 K (-2.19 %)
Jun 12 2012	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Sell	D	0.00	6,666	0	4,651,234	4.7 M to 4.7 M (-0.14 %)
Jun 07 2012	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	2.28	504	1,149	52,012	52.5 K to 52 K (-0.96 %)
Jun 07 2012	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	2.28	504	1,149	33,492	34 K to 33.5 K (-1.48 %)
Jun 07 2012	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Grant	A	2.41	6,224	15,000	20,241	14 K to 20.2 K (+44.40 %)
Jun 07 2012	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Grant	A	2.41	7,261	17,499	27,261	20 K to 27.3 K (+36.31 %)
Jun 07 2012	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Grant	A	2.41	6,224	15,000	24,577	18.4 K to 24.6 K (+33.91 %)
Jun 07 2012	AMRI	ALBANY MOLECULAR R ...	Marth William S	Director	Grant	A	2.41	12,448	30,000	12,448	0 to 12.4 K
Jun 07 2012	AMRI	ALBANY MOLECULAR R ...	LEUNG GABRIEL	Director	Grant	A	2.41	6,224	15,000	19,478	13.3 K to 19.5 K (+46.96 %)
Jun 07 2012	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Grant	A	2.41	6,224	15,000	23,304	17.1 K to 23.3 K (+36.44 %)
May 23 2012	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Buy	P	2.81	200	562	14,017	13.8 K to 14 K (+1.45 %)
May 16 2012	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	3.01	2,400	7,224	33,996	36.4 K to 34 K (-6.59 %)
Mar 21 2012	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	2.80	287	804	52,516	52.8 K to 52.5 K (-0.54 %)
Mar 21 2012	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	2.75	873	2,401	52,803	53.7 K to 52.8 K (-1.63 %)
Mar 21 2012	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	2.80	205	574	36,396	36.6 K to 36.4 K (-0.56 %)
Mar 21 2012	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	2.75	873	2,401	36,601	37.5 K to 36.6 K (-2.33 %)
Mar 08 2012	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	2.66	91	242	37,474	37.6 K to 37.5 K (-0.24 %)
Mar 08 2012	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	2.66	220	585	53,676	53.9 K to 53.7 K (-0.41 %)
Feb 22 2012	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Option Exercise	A	2.93	30,000	87,900	30,000
Feb 22 2012	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Grant	A	2.93	10,000	29,300	53,896	43.9 K to 53.9 K (+22.78 %)
Feb 21 2012	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Option Exercise	A	2.93	30,000	87,900	30,000
Feb 21 2012	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Grant	A	2.93	10,000	29,300	37,565	27.6 K to 37.6 K (+36.28 %)
Feb 21 2012	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Option Exercise	A	2.93	40,000	117,200	40,000
Feb 21 2012	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Grant	A	2.93	13,333	39,066	76,266	62.9 K to 76.3 K (+21.19 %)
Feb 21 2012	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, general counsel	Option Exercise	A	2.93	35,000	102,550	35,000
Feb 21 2012	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, general counsel	Grant	A	2.93	11,666	34,181	39,232	27.6 K to 39.2 K (+42.32 %)
Feb 21 2012	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Option Exercise	A	2.93	80,000	234,400	80,000
Feb 21 2012	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Grant	A	2.93	26,666	78,131	4,657,900	4.6 M to 4.7 M (+0.58 %)
Dec 07 2011	AMRI	ALBANY MOLECULAR R ...	LEUNG GABRIEL	Director	Buy	P	2.34	4,000	9,360	13,254	9.3 K to 13.3 K (+43.22 %)
Dec 07 2011	AMRI	ALBANY MOLECULAR R ...	LEUNG GABRIEL	Director	Buy	P	2.45	4,000	9,800	9,254	5.3 K to 9.3 K (+76.13 %)
Dec 07 2011	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, general counsel	Buy	P	2.47	5,900	14,573	27,566	21.7 K to 27.6 K (+27.23 %)
Dec 02 2011	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Buy	P	2.26	10,000	22,600	62,933	52.9 K to 62.9 K (+18.89 %)
Nov 14 2011	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	2.62	382	1,001	27,565	27.9 K to 27.6 K (-1.37 %)
Nov 08 2011	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	3.11	1,139	3,542	27,947	29.1 K to 27.9 K (-3.92 %)
Jun 09 2011	AMRI	ALBANY MOLECULAR R ...	ANDERSON PAUL S	Director	Option Exercise	A	5.28	10,000	52,800	10,000
Jun 09 2011	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Option Exercise	A	5.28	10,000	52,800	10,000
Jun 09 2011	AMRI	ALBANY MOLECULAR R ...	LEUNG GABRIEL	Director	Option Exercise	A	5.28	10,000	52,800	10,000
Jun 09 2011	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Option Exercise	A	5.28	10,000	52,800	10,000
Jun 09 2011	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Option Exercise	A	5.28	10,000	52,800	10,000
Jun 09 2011	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Option Exercise	A	5.28	10,000	52,800	10,000
Jun 06 2011	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Option Exercise	A	5.25	80,000	420,000	80,000
Jun 06 2011	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Grant	A	5.25	26,666	139,997	4,631,234	4.6 M to 4.6 M (+0.58 %)
Jun 06 2011	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Option Exercise	A	5.25	40,000	210,000	40,000
Jun 06 2011	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Grant	A	5.25	13,333	69,998	52,933	39.6 K to 52.9 K (+33.67 %)
Jun 06 2011	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, general counsel	Option Exercise	A	5.25	35,000	183,750	35,000
Jun 06 2011	AMRI	ALBANY MOLECULAR R ...	HENDERSON LORI M	VP, general counsel	Grant	A	5.25	11,666	61,247	21,666	10 K to 21.7 K (+116.66 %)
Jun 06 2011	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Option Exercise	A	5.25	30,000	157,500	30,000
Jun 06 2011	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Grant	A	5.25	10,000	52,500	41,069	31.1 K to 41.1 K (+32.19 %)
Jun 06 2011	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Option Exercise	A	5.25	30,000	157,500	30,000
Jun 06 2011	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Grant	A	5.25	10,000	52,500	29,086	19.1 K to 29.1 K (+52.39 %)
Jun 03 2011	AMRI	ALBANY MOLECULAR R ...	ANDERSON PAUL S	Director	Grant	A	5.14	2,918	14,999	13,353	10.4 K to 13.4 K (+27.96 %)
Jun 03 2011	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Grant	A	5.14	2,918	14,999	17,081	14.2 K to 17.1 K (+20.60 %)
Jun 03 2011	AMRI	ALBANY MOLECULAR R ...	LEUNG GABRIEL	Director	Grant	A	5.14	2,918	14,999	5,254	2.3 K to 5.3 K (+124.91 %)
Jun 03 2011	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Grant	A	5.14	3,891	20,000	18,353	14.5 K to 18.4 K (+26.90 %)
Jun 03 2011	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Grant	A	5.14	2,000	10,280	20,000	18 K to 20 K (+11.11 %)
Jun 03 2011	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Grant	A	5.14	2,918	14,999	13,817	10.9 K to 13.8 K (+26.77 %)
May 12 2011	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	4.84	198	958	19,086	19.3 K to 19.1 K (-1.03 %)
May 12 2011	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	4.84	237	1,147	31,069	31.3 K to 31.1 K (-0.76 %)
Mar 28 2011	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	4.18	863	3,607	31,306	32.2 K to 31.3 K (-2.68 %)
Mar 28 2011	AMRI	ALBANY MOLECULAR R ...	Sargent Bruce J	Sr VP, Drug Discove ...	Sell	S	4.46	211	941	32,169	32.4 K to 32.2 K (-0.65 %)
Mar 28 2011	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	4.18	617	2,579	19,284	19.9 K to 19.3 K (-3.10 %)
Mar 28 2011	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	4.46	87	388	19,901	20 K to 19.9 K (-0.44 %)
Dec 06 2010	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	5.20	2,000	10,400	19,988	22 K to 20 K (-9.10 %)
Nov 23 2010	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	5.77	887	5,118	21,988	22.9 K to 22 K (-3.88 %)
Nov 23 2010	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	6.09	355	2,162	22,875	23.2 K to 22.9 K (-1.53 %)
Nov 16 2010	AMRI	ALBANY MOLECULAR R ...	LEUNG GABRIEL	Director	Option Exercise	A	6.42	10,000	64,200	10,000
Jun 04 2010	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Option Exercise	A	6.15	10,000	61,500	10,000
Jun 04 2010	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Grant	A	6.15	2,439	15,000	10,899	8.5 K to 10.9 K (+28.83 %)
Jun 04 2010	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Option Exercise	A	6.15	10,000	61,500	10,000
Jun 04 2010	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Grant	A	6.15	2,439	15,000	14,462	12 K to 14.5 K (+20.29 %)
Jun 04 2010	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Option Exercise	A	6.15	10,000	61,500	10,000
Jun 04 2010	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Grant	A	6.15	2,000	12,300	18,000	16 K to 18 K (+12.50 %)
Jun 04 2010	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Option Exercise	A	6.15	10,000	61,500	10,000
Jun 04 2010	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Grant	A	6.15	4,878	30,000	14,163	9.3 K to 14.2 K (+52.54 %)
Jun 04 2010	AMRI	ALBANY MOLECULAR R ...	ANDERSON PAUL S	Director	Option Exercise	A	6.15	10,000	61,500	10,000
Jun 04 2010	AMRI	ALBANY MOLECULAR R ...	ANDERSON PAUL S	Director	Grant	A	6.15	2,439	15,000	10,435	8 K to 10.4 K (+30.50 %)
Apr 20 2010	AMRI	ALBANY MOLECULAR R ...	D AMBRA CONSTANCE M	10% Owner	Gift	G	0.00	5,500	0	4,608,428	4.6 M to 4.6 M (-0.12 %)
Apr 20 2010	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Gift	G	0.00	5,500	0	4,608,428	4.6 M to 4.6 M (-0.12 %)
Mar 22 2010	AMRI	ALBANY MOLECULAR R ...	JENNINGS WILLIAM STEVEN	Senior Vice Preside ...	Option Exercise	A	8.90	2,100	18,690	10,500
Mar 22 2010	AMRI	ALBANY MOLECULAR R ...	JENNINGS WILLIAM STEVEN	Senior Vice Preside ...	Option Exercise	A	8.90	2,100	18,690	8,400
Mar 22 2010	AMRI	ALBANY MOLECULAR R ...	JENNINGS WILLIAM STEVEN	Senior Vice Preside ...	Option Exercise	A	8.90	6,300	56,070	6,300
Mar 22 2010	AMRI	ALBANY MOLECULAR R ...	JENNINGS WILLIAM STEVEN	Senior Vice Preside ...	Grant	A	8.90	3,500	31,150	17,000	13.5 K to 17 K (+25.93 %)
Mar 22 2010	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Option Exercise	A	8.90	2,100	18,690	10,500
Mar 22 2010	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Option Exercise	A	8.90	2,100	18,690	8,400
Mar 22 2010	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Option Exercise	A	8.90	6,300	56,070	6,300
Mar 22 2010	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Grant	A	8.90	3,500	31,150	23,489	20 K to 23.5 K (+17.51 %)
Mar 22 2010	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Option Exercise	A	8.90	2,400	21,360	12,000
Mar 22 2010	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Option Exercise	A	8.90	2,400	21,360	9,600
Mar 22 2010	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Option Exercise	A	8.90	7,200	64,080	7,200
Mar 22 2010	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Grant	A	8.90	4,000	35,600	39,600	35.6 K to 39.6 K (+11.24 %)
Mar 10 2010	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	8.83	259	2,287	19,730	20 K to 19.7 K (-1.30 %)
Nov 20 2009	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	8.05	1,500	12,075	19,989	21.5 K to 20 K (-6.98 %)
Nov 16 2009	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	8.47	2,000	16,940	21,489	23.5 K to 21.5 K (-8.51 %)
Aug 06 2009	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	8.79	900	7,911	23,489	24.4 K to 23.5 K (-3.69 %)
Jun 04 2009	AMRI	ALBANY MOLECULAR R ...	TARTAGLIA ANTHONY P	Director	Option Exercise	A	8.81	10,000	88,100	10,000
Jun 04 2009	AMRI	ALBANY MOLECULAR R ...	TARTAGLIA ANTHONY P	Director	Grant	A	8.81	3,405	29,998	37,966	34.6 K to 38 K (+9.85 %)
Jun 04 2009	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Option Exercise	A	8.81	10,000	88,100	10,000
Jun 04 2009	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Grant	A	8.81	1,702	14,995	8,460	6.8 K to 8.5 K (+25.18 %)
Jun 04 2009	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Option Exercise	A	8.81	10,000	88,100	10,000
Jun 04 2009	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Option Exercise	A	8.81	10,000	88,100	10,000
Jun 04 2009	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Grant	A	8.81	1,702	14,995	12,023	10.3 K to 12 K (+16.49 %)
Jun 04 2009	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Option Exercise	A	8.81	10,000	88,100	10,000
Jun 04 2009	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Grant	A	8.81	3,405	29,998	9,285	5.9 K to 9.3 K (+57.91 %)
Jun 04 2009	AMRI	ALBANY MOLECULAR R ...	ANDERSON PAUL S	Director	Option Exercise	A	8.81	10,000	88,100	10,000
Jun 04 2009	AMRI	ALBANY MOLECULAR R ...	ANDERSON PAUL S	Director	Grant	A	8.81	1,702	14,995	7,996	6.3 K to 8 K (+27.04 %)
Mar 18 2009	AMRI	ALBANY MOLECULAR R ...	JENNINGS WILLIAM STEVEN	Senior Vice Preside ...	Option Exercise	A	8.31	2,100	17,451	10,500
Mar 18 2009	AMRI	ALBANY MOLECULAR R ...	JENNINGS WILLIAM STEVEN	Senior Vice Preside ...	Option Exercise	A	8.31	2,100	17,451	8,400
Mar 18 2009	AMRI	ALBANY MOLECULAR R ...	JENNINGS WILLIAM STEVEN	Senior Vice Preside ...	Option Exercise	A	8.31	6,300	52,353	6,300
Mar 18 2009	AMRI	ALBANY MOLECULAR R ...	JENNINGS WILLIAM STEVEN	Senior Vice Preside ...	Grant	A	8.31	3,500	29,085	13,500	10 K to 13.5 K (+35.00 %)
Mar 18 2009	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Option Exercise	A	8.31	2,100	17,451	10,500
Mar 18 2009	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Option Exercise	A	8.31	2,100	17,451	8,400
Mar 18 2009	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Option Exercise	A	8.31	6,300	52,353	6,300
Mar 18 2009	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Grant	A	8.31	3,500	29,085	24,389	20.9 K to 24.4 K (+16.76 %)
Mar 18 2009	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Option Exercise	A	8.31	2,400	19,944	12,000
Mar 18 2009	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Option Exercise	A	8.31	2,400	19,944	9,600
Mar 18 2009	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Option Exercise	A	8.31	7,200	59,832	7,200
Mar 18 2009	AMRI	ALBANY MOLECULAR R ...	Frost Mark T	Chief Financial Off ...	Grant	A	8.31	4,000	33,240	35,600	31.6 K to 35.6 K (+12.66 %)
Mar 17 2009	AMRI	ALBANY MOLECULAR R ...	D AMBRA THOMAS E PHD	Chairman, CEO & Pre ...	Gift	G	0.00	5,500	0	4,613,928	4.6 M to 4.6 M (-0.12 %)
Mar 17 2009	AMRI	ALBANY MOLECULAR R ...	D AMBRA CONSTANCE M	10% Owner	Gift	G	0.00	5,500	0	4,613,928	4.6 M to 4.6 M (-0.12 %)
Feb 12 2009	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	10.49	2,000	20,980	20,889	22.9 K to 20.9 K (-8.74 %)
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	TARTAGLIA ANTHONY P	Director	Option Exercise	A	9.19	1,667	15,320	5,000
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	TARTAGLIA ANTHONY P	Director	Option Exercise	A	9.19	1,666	15,311	3,333
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	TARTAGLIA ANTHONY P	Director	Option Exercise	A	9.19	1,667	15,320	1,667
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	Hagen Steven R	VP Pharmaceutical D ...	Sell	S	8.96	2,400	21,504	22,889	25.3 K to 22.9 K (-9.49 %)
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Option Exercise	A	9.19	1,667	15,320	5,000
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Option Exercise	A	9.19	1,666	15,311	3,333
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	RYAN UNA S	Director	Option Exercise	A	9.19	1,667	15,320	1,667
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Option Exercise	A	9.19	1,667	15,320	5,000
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Option Exercise	A	9.19	1,666	15,311	3,333
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	ROTH ARTHUR J	Director	Option Exercise	A	9.19	1,667	15,320	1,667
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	KUHLA DONALD E	Director	Option Exercise	A	9.19	1,667	15,320	5,000
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	KUHLA DONALD E	Director	Option Exercise	A	9.19	1,666	15,311	3,333
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	KUHLA DONALD E	Director	Option Exercise	A	9.19	1,667	15,320	1,667
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Option Exercise	A	9.19	1,667	15,320	5,000
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Option Exercise	A	9.19	1,666	15,311	3,333
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	OCONNOR KEVIN	Director	Option Exercise	A	9.19	1,667	15,320	1,667
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Option Exercise	A	9.19	1,667	15,320	5,000
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Option Exercise	A	9.19	1,666	15,311	3,333
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	Jordan Veronica GH	Director	Option Exercise	A	9.19	1,667	15,320	1,667
Nov 21 2008	AMRI	ALBANY MOLECULAR R ...	ANDERSON PAUL S	Director	Option Exercise	A	9.19	1,667	15,320	5,000

Page: < prev 1 ... 2 3 4 5 6 7 next >